Condition: Uterine Leiomyosarcoma · Sponsor: GOG Foundation
This is a clinical trial to test letrozole in patients with uterine leiomyosarcoma. The main question is will treatment with letrozole extend progression-free survival in patients. Patients will receive 2/5 mg of letrozole daily.
This description comes directly from the study's public registry record.
Sarin Chhab · 2158540770 · schhab@gog.org
Shanon Matkin · smatkin@gog.org
Always discuss trial participation with your own doctor first.
| University of Colorado Cancer Center - Anschutz Cancer Pavilion | Aurora, Colorado, United States | Recruiting |
| Highlands Ranch Hospital | Highlands Ranch, Colorado, United States | Recruiting |
| Broward Health Medical Center | Fort Lauderdale, Florida, United States | Recruiting |
| Mount Sinai Comprehensive Cancer Center | Miami Beach, Florida, United States | Recruiting |
| Winship Cancer Institute, Emory Hospital | Atlanta, Georgia, United States | Recruiting |
| Endeavor Health - Kellogg Cancer Center | Evanston, Illinois, United States | Recruiting |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis, Indiana, United States | Recruiting |
| LSU Health Sciences Center | New Orleans, Louisiana, United States | Recruiting |
| WK Physician Network-Gynecologic Oncology Associates | Shreveport, Louisiana, United States | Recruiting |
| University of Massachusetts Memorial Medical Center | Worcester, Massachusetts, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Women's Cancer Center of Nevada | Las Vegas, Nevada, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05649956